Segall Bryant & Hamill LLC Acquires 1,102,173 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Segall Bryant & Hamill LLC boosted its holdings in AdaptHealth Corp. (NASDAQ:AHCOFree Report) by 29.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,803,981 shares of the company’s stock after acquiring an additional 1,102,173 shares during the quarter. Segall Bryant & Hamill LLC owned 3.57% of AdaptHealth worth $45,734,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in AHCO. Pacer Advisors Inc. purchased a new stake in shares of AdaptHealth in the fourth quarter valued at about $76,271,000. FMR LLC grew its position in AdaptHealth by 9.3% in the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company’s stock worth $82,547,000 after purchasing an additional 624,645 shares in the last quarter. Reinhart Partners LLC. lifted its position in shares of AdaptHealth by 1.1% during the 4th quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company’s stock worth $59,660,000 after buying an additional 68,212 shares in the last quarter. State Street Corp lifted its position in shares of AdaptHealth by 19.8% during the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock worth $46,316,000 after buying an additional 681,816 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of AdaptHealth by 12.2% in the 3rd quarter. Geode Capital Management LLC now owns 2,451,173 shares of the company’s stock worth $27,532,000 after buying an additional 265,712 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Stock Up 4.0 %

AHCO stock opened at $10.39 on Tuesday. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90. The stock has a fifty day moving average of $10.01 and a 200-day moving average of $10.17. The company has a market capitalization of $1.40 billion, a price-to-earnings ratio of -6.30, a PEG ratio of 1.08 and a beta of 1.30. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

Analyst Ratings Changes

AHCO has been the topic of a number of recent analyst reports. Robert W. Baird lifted their price target on AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. Truist Financial lifted their target price on AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. UBS Group reduced their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Canaccord Genuity Group lifted their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Finally, Royal Bank of Canada boosted their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a research note on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $13.80.

Get Our Latest Report on AHCO

AdaptHealth Company Profile

(Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

See Also

Want to see what other hedge funds are holding AHCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AdaptHealth Corp. (NASDAQ:AHCOFree Report).

Institutional Ownership by Quarter for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.